Literature DB >> 20658464

Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population.

Xi-Dai Long1, Yun Ma, Yuan-Feng Zhou, Ai-Min Ma, Guo-Hui Fu.   

Abstract

UNLABELLED: Genetic polymorphisms in DNA repair genes may influence individual variations in DNA repair capacity, and this may be associated with the risk and outcome of hepatocellular carcinoma (HCC) related to aflatoxin B1 (AFB1) exposure. In this study, we focused on the polymorphism of xeroderma pigmentosum complementation group C (XPC) codon 939 (rs#2228001), which is involved in nucleotide excision repair. We conducted a case-control study including 1156 HCC cases and 1402 controls without any evidence of hepatic disease to evaluate the associations between this polymorphism and HCC risk and prognosis in the Guangxi population. AFB1 DNA adduct levels, XPC genotypes, and XPC protein levels were tested with a comparative enzyme-linked immunosorbent assay, TaqMan polymerase chain reaction for XPC genotypes, and immunohistochemistry, respectively. Higher AFB1 exposure was observed among HCC patients versus the control group [odds ratio (OR) = 9.88 for AFB1 exposure years and OR = 6.58 for AFB1 exposure levels]. The XPC codon 939 Gln alleles significantly increased HCC risk [OR = 1.25 (95% confidence interval = 1.03-1.52) for heterozygotes of the XPC codon 939 Lys and Gln alleles (XPC-LG) and OR = 1.81 (95% confidence interval = 1.36-2.40) for homozygotes of the XPC codon 939 Gln alleles (XPC-GG)]. Significant interactive effects between genotypes and AFB1 exposure status were also observed in the joint-effects analysis. This polymorphism, moreover, was correlated with XPC expression levels in cancerous tissues (r = -0.369, P < 0.001) and with the overall survival of HCC patients (the median survival times were 30, 25, and 19 months for patients with homozygotes of the XPC codon 939 Lys alleles, XPC-LG, and XPC-GG, respectively), especially under high AFB1 exposure conditions. Like AFB1 exposure, the XPC codon 939 polymorphism was an independent prognostic factor influencing the survival of HCC. Additionally, this polymorphism multiplicatively interacted with the xeroderma pigmentosum complementation group D codon 751 polymorphism with respect to HCC risk (OR(interaction) = 1.71).
CONCLUSION: These results suggest that the XPC codon 939 polymorphism may be associated with the risk and outcome of AFB1-related HCC in the Guangxi population and may interact with AFB1 exposure in the process of HCC induction by AFB1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658464     DOI: 10.1002/hep.23807

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  26 in total

1.  DNA repair capacity, DNA-strand break repair gene polymorphisms, and the incidence of hepatocellular carcinoma in southwestern Guangxi of China.

Authors:  Xiaoyun Zeng; Shun Liu; Hongping Yu; Long Ji; Longman Li; Jinmei Huang; Hua Bai; Xiaoqiang Qiu
Journal:  DNA Cell Biol       Date:  2012-06-12       Impact factor: 3.311

Review 2.  Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Shilu Mathew; Hany Abdel-Hafiz; Abbas Raza; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-08

Review 3.  Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis.

Authors:  Amanda K McCullough; R Stephen Lloyd
Journal:  DNA Repair (Amst)       Date:  2019-03-07

4.  CASP 3 genetic polymorphisms and risk of Hepatocellular carcinoma: a case-control study in a Chinese population.

Authors:  Benyuan Deng; Fei Liu; Limei Luo; Yonggang Wei; Bo Li; Hanteng Yang
Journal:  Tumour Biol       Date:  2016-01-12

5.  XPC codon 939 polymorphism is associated with susceptibility to DNA damage induced by aflatoxin B1 exposure.

Authors:  Xi-Dai Long; Hong-Dong Huang; Xiao-Ying Huang; Jin-Guang Yao; Qiang Xia
Journal:  Int J Clin Exp Med       Date:  2015-01-15

6.  Characterization of rare NEIL1 variants found in East Asian populations.

Authors:  Irina G Minko; Vladimir L Vartanian; Naoto N Tozaki; Oskar K Linde; Pawel Jaruga; Sanem Hosbas Coskun; Erdem Coskun; Chunfeng Qu; Huan He; Chungui Xu; Taoyang Chen; Qianqian Song; Yuchen Jiao; Michael P Stone; Martin Egli; Miral Dizdaroglu; Amanda K McCullough; R Stephen Lloyd
Journal:  DNA Repair (Amst)       Date:  2019-05-03

Review 7.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

8.  Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.

Authors:  De-Ke Jiang; Jielin Sun; Guangwen Cao; Yao Liu; Dongxin Lin; Yu-Zhen Gao; Wei-Hua Ren; Xi-Dai Long; Hongxing Zhang; Xiao-Pin Ma; Zhong Wang; Wei Jiang; Tao-Yang Chen; Yong Gao; Liang-Dan Sun; Ji-Rong Long; Hui-Xing Huang; Dan Wang; Hongjie Yu; Pengyin Zhang; Li-Sha Tang; Bo Peng; Hao Cai; Ting-Ting Liu; Ping Zhou; Fang Liu; Xiaoling Lin; Sha Tao; Bo Wan; He-Xi Ge Sai-Yin; Lun-Xiu Qin; Jianhua Yin; Li Liu; Chen Wu; Yan Pei; Yuan-Feng Zhou; Yun Zhai; Pei-Xin Lu; Aihua Tan; Xian-Bo Zuo; Jia Fan; Jiang Chang; Xiaoli Gu; Neng-Jin Wang; Yang Li; Yin-Kun Liu; Kan Zhai; Hongwei Zhang; Zhibin Hu; Jun Liu; Qing Yi; Yongbing Xiang; Rong Shi; Qiang Ding; Wei Zheng; Xiao-Ou Shu; Zengnan Mo; Yin Yao Shugart; Xue-Jun Zhang; Gangqiao Zhou; Hongbing Shen; S Lilly Zheng; Jianfeng Xu; Long Yu
Journal:  Nat Genet       Date:  2012-12-16       Impact factor: 38.330

9.  XPC Polymorphism Increases Risk of Digestive System Cancers: Current Evidence from A Meta-Analysis.

Authors:  Xia Jiang; Li-Tao Zhou; Shan-Chun Zhang; Kun Chen
Journal:  Chin J Cancer Res       Date:  2012-09       Impact factor: 5.087

10.  Molecular Epidemiology of Hepatocellular Carcinoma.

Authors:  Yujin Hoshida
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.